Faubert Lab

Select Publications

Research

Cai L, Hammond NG, Tasdogan A, Alsamraae M, Yang C, Cameron RB, Quan P, Solmonson A, Gu W, Pachnis P, Kaur M, Chang BK, Zhou Q, Hensley CT, Do QN, Martins Nascentes Melo L, Ubellacker J, Kaushik A, Clare MG, Alcazar IN, Kurylowicz K, Marcuccilli J, Allies G, Kutriz A, Klode J, Ramesh V, Rogers TJ, Rao A, Crentsil HE, Li H, Brister F, McDaniel P, Xu X, Evers BM, Zacharias LG, Sudderth J, Xu J, Mathews TP, Oliver D, Minna JD, Waters J, Morrison SJ, Kernstine KH, Faubert B, DeBerardinis RJ. High glucose contribution to the TCA cycle is a feature of aggressive non-small cell lung cancer in patients.
Cancer Discovery (2025)

Lee HM, Muhammad N, Lieu EL, Cai F, Mu J, Cao G, Suchors C Jones K, Chornis C, Li K, Ducker GS, Olszewski K, Cai L, Allison DB, Backer Se, Ewing WR, Wong H, Seo H, Faubert B, Kim J, Kim J. Concurrent loss of LKB1 and KEAP1 enhances SHMT-mediated antioxidant defence in KRAS-mutant lung cancer.
Nature Metabolism (2024)

Reviews

Hammond NG, Cameron RB, Faubert B. Beyond glucose and Warburg: Finding the sweet spot in cancer metabolism models.
NPG Metabolic Health and Disease (2024)

Bartman C, Faubert B, Rabinowitz JD, DeBerardinis RJ. Metabolic pathway analysis using stable isotopes in patients with cancer.
Nature Reviews Cancer (2023)

Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression.
Science (2020)

Scroll to Top